Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion
Camilleri, Michael , Shin, Andrea , Busciglio, Irene, Carlson, Paula, Bharucha, Adil E. , Burton, Duane, Lamsam, Jesse, Lueke, Alan J., Zinsmeister, Alan R., Lueke, Alan, Donato, Leslie J. , Acosta, Andrés

American Journal of Physiology-Gastrointestinal and Liver Physiology | July 10, 2014 | Volume: 307 | Issue: 5 | Pages: G508-G516

10.1152/ajpgi.00178.2014 | PMID 25012842 Get It

The pathobiology of irritable bowel syndrome (IBS) is multifaceted. We aimed to identify candidate genes predisposing to quantitative traits in IBS. In 30 healthy volunteers, 30 IBS-constipation, and 64 IBS-diarrhea patients, we measured bowel symptoms, bile acid (BA) synthesis (serum 7α-hydroxy-4-cholesten-3-one and FGF19), fecal BA and fat, colonic transit (CT by scintigraphy), and intestinal permeability (IP by 2-sugar excretion). We assessed associations of candidate genes controlling BA metabolism ( KLB rs17618244 and FGFR4 rs351855), BA receptor ( GPBAR1 rs11554825), serotonin (5-HT) reuptake ( SLC6A4 through rs4795541 which encodes for the 44-bp insert in 5HTTLPR), or immune activation ( TNFSF15 rs4263839) with three primary quantitative traits of interest: colonic transit, BA synthesis, and fecal BA excretion. There were significant associations between fecal BA and CT at 48 h ( r = 0.43; P < 0.001) and IP ( r = 0.23; P = 0.015). GPBAR1 genotype was associated with CT48 ( P = 0.003) and total fecal BA [ P = 0.030, false detection rate (FDR) P = 0.033]. Faster CT48 observed with both CC and TT GPBAR1 genotypes was due to significant interaction with G allele of KLB, which increases BA synthesis and excretion. Other univariate associations ( P < 0.05, without FDR correction) observed between GPBAR1 and symptom phenotype and gas sensation ratings support the role of GPBAR1 receptor. Associations between SLC6A4 and stool consistency, ease of passage, postprandial colonic tone, and total fecal BA excretion provide data in support of future hypothesis-testing studies. Genetic control of GPBAR1 receptor predisposing to pathobiological mechanisms in IBS provides evidence from humans in support of the importance of GPBAR1 to colonic motor and secretory functions demonstrated in animal studies.
Screening, Confirming, and Treating Amblyopia Based on Binocularity
Holmes, Jonathan M. , Holmes, Jonathan M.

JAMA Ophthalmology | July 10, 2014 | Volume: 132 | Issue: 7 | Pages: 820

10.1001/jamaophthalmol.2014.2455 | PMID 25010167 Get It

Sport Modality Affects Bradycardia Level and Its Mechanisms of Control in Professional Athletes
Azevedo, L.S. , Perlingeiro, Patrícia de Sá, Allison, Thomas G. , Hachul, Denise , Gomes‐Santos, Igor L. , Brum, Patrı́cia C. , Negrão, Carlos Eduardo , Matos, Luciana Diniz Nagem Janot de

International Journal of Sports Medicine | July 10, 2014 | Volume: 35 | Issue: 11 | Pages: e3-e3

10.1055/s-0034-1384589 | PMID 25009963 Get It

Assessment of Gait Kinetics Using Triaxial Accelerometers
Fortune, Emma , Morrow, Melissa M. , Kaufman, Kenton R. , Morrow, Melissa M , Kaufman, Kenton R

Journal of Applied Biomechanics | July 10, 2014 | Volume: 30 | Issue: 5 | Pages: 668-674

10.1123/jab.2014-0037 | PMID 25010675 Get It

Repeated durations of dynamic activity with high ground reaction forces (GRFs) and loading rates (LRs) can be beneficial to bone health. To fully characterize dynamic activity in relation to bone health, field-based measurements of gait kinetics are desirable to assess free-living lower-extremity loading. The study aims were to determine correlations of peak vertical GRF and peak vertical LR with ankle peak vertical accelerations, and of peak resultant GRF and peak resultant LR with ankle peak resultant accelerations, and to compare them to correlations with tibia, thigh, and waist accelerations. GRF data were collected as ten healthy subjects (26 [19–34] years) performed 8–10 walking trials at velocities ranging from 0.19 to 3.05 m/s while wearing ankle, tibia, thigh, and waist accelerometers. While peak vertical accelerations of all locations were positively correlated with peak vertical GRF and LR (r2 > .53, P < .001), ankle peak vertical accelerations were the most correlated (r2 > .75, P < .001). All peak resultant accelerations were positively correlated with peak resultant GRF and LR (r2 > .57, P < .001), with waist peak resultant acceleration being the most correlated (r2 > .70, P < .001). The results suggest that ankle or waist accelerometers give the most accurate peak GRF and LR estimates and could be useful tools in relating physical activity to bone health.
Clinical predictors of recurrent Clostridium difficile infection in out‐patients
Shivashankar, Raina , Khanna, Sahil , Kammer, Patricia P., Harmsen, William S. , Zinsmeister, Alan R., Pardi, Darrell S. , Baddour, Larry M.

Alimentary Pharmacology & Therapeutics | July 10, 2014 | Volume: 40 | Issue: 5 | Pages: 518-522

10.1111/apt.12864 | PMID 25039269 Get It

SummaryBackgroundClostridium difficile infection (CDI) recurs in 20–30% of patients.AimTo describe the predictors of recurrence in out‐patients with CDI.MethodsOut‐patient cases of CDI in Olmsted County, MN residents diagnosed between 28 June 2007 and 25 June 2010 were identified. Recurrent CDI was defined as recurrence of diarrhoea with a positive C. difficile PCR test from 15 to 56 days after the initial diagnosis with interim resolution of symptoms. Patients who had two positive tests within 14 days were excluded. Cox proportional hazard models were used to assess the association of clinical variables with time to recurrence of CDI.ResultsThe cohort included 520 out‐patients; 104 had recurrent CDI (cumulative incidence of 17.5% by 30 days). Univariate analysis identified increasing age and antibiotic use to be associated with recurrent CDI. Severe CDI, peripheral leucocyte count and change in serum creatinine >1.5‐fold were not. In a multiple variable model, concomitant antibiotic use was associated with risk of recurrent CDI (HR = 5.4, 95% CI 1.6–17.5, P = 0.005), while age (HR per 10 year increase = 1.1, 95% CI 0.9–1.3, P = 0.22); peripheral leucocyte count >15 × 109/L (HR = 1.0, 95% CI 0.5–2.1, P = 0.92); and change in serum creatinine greater than 1.5‐fold (HR = 0.8, 95% CI 0.4–1.5, P = 0.44) were not.ConclusionsAntibiotic use was independently associated with a dramatic risk of recurrent Clostridium difficile infection in an out‐patient cohort. It is important to avoid unnecessary systemic antibiotics in patients with Clostridium difficile infection, and patients with ongoing antibiotic use should be monitored closely for recurrent infection.
Sequence of Events in Measles Virus Replication: Role of Phosphoprotein-Nucleocapsid Interactions
Brunel, Joanna , Chopy, Damien, Dosnon, Marion, Bloyet, Louis-Marie , Devaux, Patricia , Urzua, Érica, Cattaneo, Roberto , Longhi, Sonia , Gerlier, Denis , Gerlier, Denis

Journal of Virology | July 10, 2014 | Volume: 88 | Issue: 18 | Pages: 10851-10863

10.1128/jvi.00664-14 | PMID 25008930 Get It

ABSTRACT The genome of nonsegmented negative-strand RNA viruses is tightly embedded within a nucleocapsid made of a nucleoprotein (N) homopolymer. To ensure processive RNA synthesis, the viral polymerase L in complex with its cofactor phosphoprotein (P) binds the nucleocapsid that constitutes the functional template. Measles virus P and N interact through two binding sites. While binding of the P amino terminus with the core of N (N CORE ) prevents illegitimate encapsidation of cellular RNA, the interaction between their C-terminal domains, P XD and N TAIL is required for viral RNA synthesis. To investigate the binding dynamics between the two latter domains, the P XD F497 residue that makes multiple hydrophobic intramolecular interactions was mutated. Using a quantitative mammalian protein complementation assay and recombinant viruses, we found that an increase in P XD -to-N TAIL binding strength is associated with a slower transcript accumulation rate and that abolishing the interaction renders the polymerase nonfunctional. The use of a newly developed system allowing conditional expression of wild-type or mutated P genes, revealed that the loss of the P XD -N TAIL interaction results in reduced transcription by preformed transcriptases, suggesting reduced engagement on the genomic template. These intracellular data indicate that the viral polymerase entry into and progression along its genomic template relies on a protein-protein interaction that serves as a tightly controlled dynamic anchor. IMPORTANCE Mononegavirales have a unique machinery to replicate RNA. Processivity of their polymerase is only achieved when the genome template is entirely embedded into a helical homopolymer of nucleoproteins that constitutes the nucleocapsid. The polymerase binds to the nucleocapsid template through the phosphoprotein. How the polymerase complex enters and travels along the nucleocapsid template to ensure uninterrupted synthesis of up to ∼6,700-nucleotide messenger RNAs from six to ten consecutive genes is unknown. Using a quantitative protein complementation assay and a biGene-biSilencing system allowing conditional expression of two P genes copies, the role of the P-to-N interaction in polymerase function was further characterized. We report here a dynamic protein anchoring mechanism that differs from all other known polymerases that rely only onto a sustained and direct binding to their nucleic acid template.
How much evidence does it take? A cumulative meta‐analysis of outcomes of simulation‐based education
Cook, David A.

Medical Education | July 10, 2014 | Volume: 48 | Issue: 8 | Pages: 750-760

10.1111/medu.12473 | PMID 25039731 Get It

Context Studies that investigate research questions that have already been resolved represent a waste of resources. However, the failure to collect sufficient evidence to resolve a given question results in ambiguity. Objectives The present study was conducted to reanalyse the results of a meta‐analysis of simulation‐based education ( SBE ) to determine: (i) whether researchers continue to replicate research studies after the answer to a research question has become known, and (ii) whether researchers perform enough replications to definitively answer important questions. Methods A systematic search of multiple databases to May 2011 was conducted to identify original research evaluating SBE for health professionals in comparison with no intervention or any active intervention, using skill outcomes. Data were extracted by reviewers working in duplicate. Data synthesis involved a cumulative meta‐analysis to illuminate patterns of evidence by sequentially adding studies according to a variable of interest (e.g. publication year) and re‐calculating the pooled effect size with each addition. Cumulative meta‐analysis by publication year was applied to 592 comparative studies using several thresholds of ‘sufficiency’, including: statistical significance; stable effect size classification and magnitude (Hedges’ g ± 0.1), and precise estimates (confidence intervals of less than ± 0.2). Results Among studies that compared the outcomes of SBE with those of no intervention, evidence supporting a favourable effect of SBE on skills existed as early as 1973 (one publication) and further evidence confirmed a quantitatively large effect of SBE by 1997 (28 studies). Since then, a further 404 studies were published. Among studies comparing SBE with non‐simulation instruction, the effect initially favoured non‐simulation training, but the addition of a third study in 1997 brought the pooled effect to slightly favour simulation, and by 2004 (14 studies) this effect was statistically significant (p < 0.05) and the magnitude had stabilised (small effect). A further 37 studies were published after 2004. By contrast, evidence from studies evaluating repetition continued to show borderline statistical significance and wide confidence intervals in 2011. Conclusions Some replication is necessary to obtain stable estimates of effect and to explore different contexts, but the number of studies of SBE often exceeds the minimum number of replications required.
In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association
Jaffe, Allan S. , Möeckel, Martin , Huber, Kurt , Mair, Johannes , Mueller, Christian, Thygesen, Kristian , Möckel, Martin , Jaffe, Allan S. , Giannitsis, Evangelos , Plebani, Mario , Lindahl, Bertil , Huber, Kurt , Mockel, Martin

European Heart Journal: Acute Cardiovascular Care | July 9, 2014 | Volume: 3 | Issue: 4 | Pages: 313-316

10.1177/2048872614541906 | PMID 25009249 Get It

Novel compounds for therapy: antibiotics and alternative therapies
Hammer, Kimberly , Rohrich, Melissa , Wieser, Catherine, Lo, Tze Shien

Clinical Insights:<i>Staphylococcus aureus</i>Antibiotic Resistance | July 9, 2014 | Volume: No volume available | Issue: No issue available | Pages: 113-134

10.2217/ebo.13.556 Get It

Phase III double‐blind, placebo‐controlled study of gabapentin for the prevention of delayed chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)
Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. , Diekmann, Brent, Fuloria, Jyotsna, Kottschade, Lisa A. , Lyss, Alan P., Jaslowski, Anthony J., Mazurczak, Miroslaw, Blair, Scott C., Terstriep, Shelby A., Loprinzi, Charles L.

Cancer | July 9, 2014 | Volume: 120 | Issue: 22 | Pages: 3575-3583

10.1002/cncr.28892 | PMID 25043153 Get It

BACKGROUNDDespite targeted antiemetics, data support an unmet need related to the management of delayed nausea and vomiting (NV). Promising pilot data informed this phase III trial evaluating gabapentin for delayed NV from highly emetogenic chemotherapy (HEC).METHODSParticipants were randomized to receive prophylactic treatment with 20 mg of dexamethasone and a 5HT3 receptor antagonist (RA) on the day of chemotherapy, followed by gabapentin 300 mg twice a day and dexamethasone (dex) or placebo and dex after HEC. Gabapentin/placebo was started the day of chemotherapy and continued through day 5 for the first chemotherapy cycle, whereas dex was titrated down on days 2‐4. The primary end point was complete response (CR), defined as no emesis and no use of rescue medications on days 2‐6, using an NV diary. The percentages of those in each group with a CR were compared by Fisher's exact test.RESULTSFour hundred thirty patients were enrolled in this study. Forty‐seven percent of patients in the gabapentin arm and 41% in the placebo arm had a CR (P = .23). Mean number of emesis episodes was <0.5 daily, and mean nausea severity was < 2 (mild). In both arms, patient satisfaction with NV control was greater than 8 (with 10 being perfectly satisfied). There were no significant differences in unwanted side effects.CONCLUSIONSIn this study, gabapentin did not significantly improve delayed NV. Patients were satisfied with the control of their nausea and vomiting irrespective of arm. The use of a 5HT3 RA and dexamethasone provided good control of nausea and vomiting for most patients. Cancer 2014;120:3575–3583. © 2014 American Cancer Society.